US9447087, 106

ID: ALA3910534

PubChem CID: 46926063

Max Phase: Preclinical

Molecular Formula: C21H22ClN7O2

Molecular Weight: 439.91

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  CC1=C(C(=O)NC2CCCC2)C(c2n[nH]cc2Cl)N=C(Nc2nc3ccccc3o2)N1

Standard InChI:  InChI=1S/C21H22ClN7O2/c1-11-16(19(30)25-12-6-2-3-7-12)18(17-13(22)10-23-29-17)27-20(24-11)28-21-26-14-8-4-5-9-15(14)31-21/h4-5,8-10,12,18H,2-3,6-7H2,1H3,(H,23,29)(H,25,30)(H2,24,26,27,28)

Standard InChI Key:  PAJGMPJNIZDZFW-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 31 35  0  0  0  0  0  0  0  0999 V2000
   -1.6572   -7.0081    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4572   -7.0123    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2883   -8.3139    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7883   -8.3192    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5428   -7.0227    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.7974   -5.7210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5497   -4.4224    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.8032   -3.1233    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4133   -1.7530    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.2990   -0.7500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2990    0.7500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    1.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2990    0.7500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2990   -0.7500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000   -1.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3114   -2.9665    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.2973   -5.7159    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.5341   -9.6214    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0147   -9.7621    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.3238  -11.2299    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.0234  -11.9775    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9106  -10.9717    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7349  -11.2120    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.4640   -9.6126    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6640   -9.6106    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.2838  -10.9139    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4685  -12.2126    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1479  -13.5662    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9703  -14.5660    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2668  -13.8115    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9498  -12.3453    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
 15 16  1  0
 16  8  2  0
  6 17  1  0
 17  2  1  0
  4 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  1  0
 21 22  2  0
 22 18  1  0
 22 23  1  0
  3 24  1  0
 24 25  2  0
 24 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 31 27  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA3910534

   2-(1,3-benzoxazol-2-ylamino)-4-(4-chloro-1H-pyrazol-5-yl)-N-cyclopentyl-6-methyl-1,4-dihydropyrimidine-5-carboxamide

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 439.91

Molecular Weight (Monoisotopic): 439.1524

AlogP: 3.65

#Rotatable Bonds: 4

Polar Surface Area: 120.23

Molecular Species: NEUTRAL

HBA: 7

HBD: 4

#RO5 Violations: ┄

HBA (Lipinski): 9

HBD (Lipinski): 4

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 11.50

CX Basic pKa: 4.71

CX LogP: 2.81

CX LogD: 2.81

Aromatic Rings: 3

Heavy Atoms: 31

QED Weighted: 0.49

Np Likeness Score: -1.19

References

1.  (2016)  Galactokinase inhibitors for the treatment and prevention of associated diseases and disorders, 

2.  (2019)  Galactokinase inhibitors for the treatment and prevention of associated diseases and disorders, 

Source

Source(2):

• BindingDB Database
• Patent Bioactivity Data